Regarding IGF2BP3, all four pancreatic cancer datasets indicated overexpression in both pancreatic carcinoma and pancreatic ductal adenocarcinoma (Table 1) [12–16]. Here, IGF2BP3 is linked to pancreatic ductal adenocarcinoma.